Contents
Telehealth fraud cases involve visits billed without patients, prescriptions driven by sales targets, purchased doctors’ orders and monitoring claims that misrepresent the work performed. The person approving an order may work for a different business from the one billing Medicare. The platform may decide what appears in the chart before a clinician opens it. If you handle scheduling, clinical records, software, staffing or billing, you may know where the account sent to the government stopped matching what happened.
Encounter billing cases concern whether the visit happened, what work it involved and whose credentials appeared on the claim. Aptihealth, Circle Medical and Physician Partners of America show different ways those details can change what a health plan pays.
Aptihealth’s June 2026 settlement agreement records admissions about no-show claims to Medicare and Medicaid and message billing that ignored clinical content. Its case turns on the gap between the appointment or exchange and the service billed.
Circle Medical’s June 2026 settlement concerned alleged billing under clinicians who neither performed nor supervised the care. It covered federal healthcare program claims and California commercial-insurance claims.
Physician Partners of America allegedly required recurring telemedicine appointments regardless of medical need after Florida paused non-emergency procedures during the pandemic. The Justice Department also alleged inappropriate use of high-level visit codes.
The company’s April 2022 settlement covered the recurring visits and high-level billing codes. The remote-care allegation was particularly direct: the business allegedly replaced lost procedure revenue by requiring more appointments.
An order mill sells the authorization that lets another business bill for equipment, laboratory tests or drugs. The Health and Human Services Inspector General’s telemedicine fraud alert describes recruited beneficiaries, preselected products, little patient contact and payments tied to order volume. It also identifies arrangements without meaningful follow-up.
That explains why the order deserves attention alongside the visit. A supplier or laboratory can submit the expensive claim while a separate company pays for the practitioner’s signature.
Jackson & Coker LocumTenens and a physician made factual admissions in their March 2024 civil settlement. Approval-linked staffing fees connected the company to orders used for Medicare claims, even though it did not bill Medicare itself.
HealthSplash owned DMERx, a platform that generated doctors’ orders for durable medical equipment and prescriptions. In the Justice Department’s account of the criminal trial, the platform connected marketers, suppliers and pharmacies with telemedicine companies accepting payments for signed orders. A jury convicted HealthSplash’s owner in May 2026.
The trial evidence included an undercover beneficiary pushed toward multiple braces by a call center. A doctor then signed an order asserting that tests requiring an in-person examination had been performed. The doctor had never even spoken with the supposed patient.
Medicare and other insurers paid claims based on these false orders. Taxpayers funded equipment sales built on examinations that never happened.
The software gave the supplier a clinical account that the patient encounter could not support. Someone who knows the templates, the order-routing process or how the signature was applied may understand that discrepancy better than someone reading the final form.
A physician’s April 2026 civil settlement included admissions about unsupported genetic-test approvals through MySpecialistMD. The physician’s case shows how a portal approval could create signed medical-necessity paperwork.
Genexe and Immerge, together with two executives, agreed to a settlement in April 2025. The government alleged that contractors recruited beneficiaries at places such as stores, fairs and retirement centers, collected samples, and obtained physician orders through telemedicine companies or laboratory arrangements. Samples and orders went to laboratories in exchange for a portion of Medicare receipts.
Vici Marketing and HealthRight appeared in a separate civil settlement announced in August 2019. The government alleged that the settling marketing businesses obtained insurance information, arranged unnecessary prescriptions without valid physician-patient relationships and sold the prescriptions to pharmacies as marketing services priced by volume and value.
In both accounts, recruitment supplied the patient information and the remote order supplied the paperwork needed for another business to bill. The marketing agreement and the clinical record described different parts of the same transaction.
Prescribing cases can turn on compensation, refill design and instructions that push clinicians toward a predetermined result. Done and Cerebral show how those decisions can reach from a subscription business into the prescription and the insurer’s payment.
The Justice Department’s account of Done’s criminal trial describes automatic refills that reduced follow-up and false prior authorizations used to obtain payment from Medicare, Medicaid and commercial insurers. The trial resulted in convictions of its founder and former clinical president.
Under its November 2024 criminal non-prosecution agreement, Cerebral admitted a prescribing target for initial medication-management visits. That company-level target is the connection between its business decisions and clinicians’ prescriptions.
Remote patient monitoring separates device setup, data transmission and treatment management. Those components produce different records. Cardiac monitoring and remote interpretation add their own questions about which service was selected, who reviewed the data and where the work occurred.
Health Wealth Safe and a physician paid a civil settlement announced in June 2025. The government alleged Medicare claims for monitoring patients whose devices lacked the connectivity needed to report readings automatically. Former employees supplied the information behind the investigation.
LiveCare‘s January 2025 settlement concerned a different transaction. The company provided remote monitoring for patients with Type 2 diabetes and allegedly paid a marketing service unlawful referral fees for Medicare beneficiaries.
One case directs attention to how a reading reached the monitoring company. The other directs attention to how the beneficiary reached it.
Marshfield Medical, formerly Bromedicon, agreed to a settlement in March 2018. It allegedly billed remote surgical monitoring as though a licensed physician continuously interpreted the data. In some instances nobody monitored the stream. In others, the reviewer was a foreign medical-school graduate without a U.S. medical license.
The service depended on a remote interpreter communicating with a technician in the operating room. Staffing records and communications during surgery could show who actually performed that work.
The same company name can lead to different cases. The cardiac-monitoring settlements address distinct decisions inside the business, while RediDoc connects proceedings involving different participants.
| Company or Network | Separate Proceeding | What the Case Concerns |
|---|---|---|
| LifeWatch Services | March 2012 settlement | Alleged false diagnostic codes and free staff supplied to induce monitoring referrals. |
| BioTelemetry and CardioNet | March 2015 settlement | Alleged use of inaccurate diagnostic codes to bill for more expensive cardiac monitoring. |
| MedNet | November 2016 settlement | Alleged referral incentives through discounted monitoring that customers billed to Medicare. The conduct preceded BioTelemetry’s acquisition of MedNet. |
| BioTelemetry and CardioNet | December 2022 settlement | Alleged review of federal beneficiaries’ cardiac data in India and deficient technician credentials. |
| BioTelemetry and LifeWatch | December 2023 settlement | Alleged enrollment choices that selected a more expensive monitoring service than physicians intended. |
| RediDoc | Managers’ May 2022 criminal guilty pleas; a recorded-call physician’s January 2024 settlement; a Wilmington physician’s September 2024 settlement | The managers admitted receiving marketer money and paying doctors. The physicians’ settlements concerned their respective roles in signing equipment orders through RediDoc. |
Telehealth settlement figures describe agreed payments, judgments state court-ordered obligations, and collected recoveries are money reported as paid. These examples distinguish the amounts without combining separate parties’ obligations.
| Kind of Amount | Case Example | What the Figure Means |
|---|---|---|
| Settlement principal | Aptihealth: $300,000 | Combined federal and New York principal. The federal portion follows an installment schedule. |
| Admitted liability and agreed payment | Paid equipment and genetic-test orders: $11,025,088 in admitted liability; $561,800 agreed payment | The physician’s consent-judgment terms allow the smaller payment to fulfill the obligation. |
| Judgment | Premier Medical: $71,015,256 | The court ordered the laboratory to pay this amount in a default judgment. |
| Collected payment | Premier Medical’s former compliance executive: $15,000 | The Justice Department reports that the executive paid this amount to resolve the allegations against him. It is a separate participant’s payment. |
The physician resolution and the Premier Medical announcement distinguish the obligations and payments within those cases. Their full case accounts carry the payment details. Our telehealth whistleblower rewards page explains how the recovery relates to a whistleblower’s share. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
The useful evidence connects a business decision to a false claim, as the case examples above show. Our telehealth fraud evidence guide covers the records behind that connection. Our whistleblower experts work with you to turn that inside knowledge into a case strategy.
The 2024 Rutgers University Law Review article Plausible Cause: Connecting the FCA and AKS in the Context of Health Care Fraud examines the connection between kickbacks and the claims they produce. It makes a practical observation: companies hold their own records and understand their billing processes. Across these telehealth cases, that is why an insider’s explanation of how an approval became a bill can matter as much as the final document.
If you recognize a no-show turned into a visit, a paid signature or monitoring that existed only on a claim, talk with our telehealth fraud whistleblower experts. We build the case strategy with you and bring in healthcare fraud whistleblower lawyers who understand the encounter, the order and the reimbursement. We stay beside you through the decisions that turn your knowledge of the business into a whistleblower case.